<DOC>
	<DOCNO>NCT00245947</DOCNO>
	<brief_summary>Evaluate response inflammatory serum marker oral ERB-041 subject inflammation associate active Crohn 's disease .</brief_summary>
	<brief_title>Study Evaluating ERB-041 Active Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Men woman , minimum 18 year age diagnosis Crohn 's disease great 3 month , Eligible subject must adequate hematologic , renal , hepatic function . Other inclusion apply Use follow medication within specified time period randomization prohibit : Within 48 hour randomization Nonsteroidal antiinflammatory drug ( NSAIDs ) Within 2 week randomization Herbal supplement ( except daily multivitamin/mineral supplement contain herbal component ) . Other exclusion applies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Inflammation</keyword>
</DOC>